Details checkedClinical trial listing onlyCheckedregistry

Vitamin D Supplementation Study for Idiopathic Sudden Sensorineural Hearing Loss

Also known as: Vitamin D Supplementation+ standard treatment, Mechanism and Application of Vitamin D in Idiopathic Sudden Sensorineural Hearing Loss, standard treatment, NCT07045883

Institution-led study

Primary source

Sponsor / Institution

Institution-led study

Program Type

Therapeutic

Modality

Small Molecule

Stage

Interventional/NA

Status

Active

Target Gene

—

Route / Mode

Oral vitamin D3 adjunct to standard treatment

Confidence

84%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-10

Geography

China

Population

adult, sudden, sensorineural

Trial IDs

Mechanism

Institution-led interventional study evaluating oral vitamin D3 supplementation plus standard treatment compared with standard treatment alone in idiopathic sudden sensorineural hearing loss.

Indications

Hearing Loss Sensorineural Hearing Loss Sudden Sensorineural Hearing Loss

Notes

Collapsed the generated standard-treatment comparator arm into this vitamin D study-level record for NCT07045883. Standard treatment is a comparator/workflow arm and should not appear as a separate HearScape therapeutic program.

Evidence & Sources

1 structured sources

clinicaltrials

Supports: canonicalName, aliases, company, allCompanies, isIndustrySponsored, programType, modality, mechanism...

IDs: NCT07045883

Open

Key Events

2025-06-01

Registry lists actual study start for vitamin D supplementation in idiopathic SSNHL

Clinical Trials (1)

NCT07045883

Data Checks